Identification by phage display and characterization of two neutralizing chimpanzee monoclonal antibodies to the hepatitis E virus capsid protein.
about
The open reading frame 3 gene of hepatitis E virus contains a cis-reactive element and encodes a protein required for infection of macaquesA C-terminal Hydrophobic Region is Required for Homo-Oligomerization of the Hepatitis E Virus Capsid (ORF2) ProteinHepatitis E virus as an emerging zoonotic pathogenBiological and immunological characteristics of hepatitis E virus-like particles based on the crystal structureMolecular Biology and Infection of Hepatitis E VirusReview article: hepatitis E-a concise review of virology, epidemiology, clinical presentation and therapy.A Comprehensive Study of Neutralizing Antigenic Sites on the Hepatitis E Virus (HEV) Capsid by Constructing, Clustering, and Characterizing a Tool Box.Neutralizing human Fab fragments against measles virus recovered by phage displayIdentification of chimpanzee Fab fragments by repertoire cloning and production of a full-length humanized immunoglobulin G1 antibody that is highly efficient for neutralization of dengue type 4 virus.Chimpanzee Fab fragments and a derived humanized immunoglobulin G1 antibody that efficiently cross-neutralize dengue type 1 and type 2 viruses.Construction of human Fab library and isolation of monoclonal Fabs with rabies virus-neutralizing ability.Hepatitis E Virus (HEV) strains in serum samples can replicate efficiently in cultured cells despite the coexistence of HEV antibodies: characterization of HEV virions in blood circulation.A truncated hepatitis E virus ORF2 protein expressed in tobacco plastids is immunogenic in mice.Proteomic analysis of Singapore grouper iridovirus envelope proteins and characterization of a novel envelope protein VP088.Essential elements of the capsid protein for self-assembly into empty virus-like particles of hepatitis E virus.Generation and Characterization of an scFv Directed against Site II of Rabies Glycoprotein.Molecular virology of hepatitis E virus.Cytokine profiles, CTL response and T cell frequencies in the peripheral blood of acute patients and individuals recovered from hepatitis E infection.Pathogenesis of hepatitis E virus and hepatitis C virus in chimpanzees: similarities and differencesDevelopment of anti-infectives using phage display: biological agents against bacteria, viruses, and parasites.Hepatitis E: an overview and recent advances in vaccine research.Survey of the year 2000 commercial optical biosensor literature.Chimpanzees as an animal model for human norovirus infection and vaccine development.Chimpanzee/human mAbs to vaccinia virus B5 protein neutralize vaccinia and smallpox viruses and protect mice against vaccinia virus.Molecular biology and replication of hepatitis E virus.Spatial configuration of hepatitis E virus antigenic domain.The use of an in vitro microneutralization assay to evaluate the potential of recombinant VP5 protein as an antigen for vaccinating against Grass carp reovirus.ORF3 protein of hepatitis E virus is not required for replication, virion assembly, or infection of hepatoma cells in vitro.Structural basis for the neutralization of hepatitis E virus by a cross-genotype antibody.Characterization of the VP39 envelope protein from Singapore grouper iridovirus.Recombinant antibodies for diagnostics and therapy against pathogens and toxins generated by phage display.Crystallization and preliminary X-ray diffraction analysis of recombinant hepatitis E virus-like particle.Cellular immune responses in acute hepatitis E virus infection to the viral open reading frame 2 protein.Antigenic determinants of hepatitis E virus and vaccine-induced immunogenicity and efficacy.Hepatitis E vaccine.Hepatitis E virus infections in humans and animalsIn vitro and in vivo mutational analysis of the 3'-terminal regions of hepatitis e virus genomes and repliconsHepatitis E virus: neutralizing sites, diagnosis, and protective immunity.Gene expression profiles of T cells from hepatitis E virus infected patients in acute and resolving phase.Design and evaluation of a recombinant multi-epitope-based ELISA for the serological surveillance of HEV infection in northern China.
P2860
Q24524173-EC6051B8-99EF-4165-9663-787F5EF34194Q24806456-8F898623-47B8-4F59-A02C-E3649320854CQ26751267-ADA2F427-A7B3-4591-AD70-C64E666D99A5Q27646563-51369F4D-FA2D-4A8C-84D3-82D65AEEFC1BQ28066101-80460CD6-A188-468E-B439-CB24CE01AC7BQ30234629-A2CCB20F-02F4-41D2-8FE8-4C7AFFC3D5F0Q30375781-CA88D6B0-0BDD-4DE3-94EB-C7CBDC35A92DQ31032269-B2D0D1B9-365F-4F5B-AD41-25B11C987823Q33201423-46914E5E-6B75-4328-8828-205BF2A7A523Q33208947-1885EC53-C42D-49CB-AD4A-7D900EDC26BFQ33214241-ADA0D357-3A15-47CE-8A8F-D52CAACDB0B0Q33769640-3B7A9EB7-98DB-439F-87AC-B22B327CFD05Q33788163-15284F2D-5846-4F37-BF86-E3F891696AE2Q33888451-65C04F32-8C87-403B-BEED-EBCDF552F7FFQ34045644-8D8106C4-77E1-47D2-8BA2-5995E31EE87FQ34050438-A05633F9-A553-40A6-866F-E66151B80586Q34166393-66609319-09C6-42E3-8E44-C0A6993320AEQ34181974-CDF3F882-6277-482B-9B2B-0E43FA1C70EDQ34190622-3E232794-A178-43B6-B755-27CE84B25771Q34291876-AD3E83E4-F70D-4A0D-B248-25F8A03D1060Q34334086-AE1C44BA-37CF-4FB4-8361-BB990144315FQ34464911-FAE80A39-09B4-4D32-A93D-DD6E1E597FDFQ34471908-3FF709A9-FBA8-4C18-83B1-7767128B8AADQ34478724-8460DD57-19B9-4800-A5CC-3CB6BE4116F1Q34479052-C859EC04-B0FB-40AC-BB5F-96C9AE6A78EDQ34485189-F08C6346-C29F-43FB-AE00-AA70EB1FC713Q34761432-719019DA-095B-4B0B-8454-5BF62CE0834FQ35139263-1B75D79D-88C9-4837-818C-86D7A43D1DC4Q35578943-129F53A5-B76D-42F4-8E83-F28ACB260E1FQ35829196-CFC8B111-2ECA-4712-AD1B-3E895104C8C3Q36023082-D6207082-A397-46EA-B669-91C09040970CQ36640766-E023E0B5-9F7A-48AA-BA30-AD535D5FC8F8Q36743863-939699E7-7F05-41ED-BF40-54C9EFA0EC07Q36973372-6F7A9562-E94A-4F49-B97A-E156122CEFC0Q37278231-FBD91556-B716-4802-A1AE-6BDB8CD80591Q37473517-8ED2BA3F-DD05-42EB-9D6A-ACA79FD42E51Q37742786-83C3E093-E2F3-4D32-A100-7B9BF8E85286Q38014371-5FDAE0B1-7553-48D8-8F40-8CD77FD9ADA4Q38503516-C4BCACA3-E083-44C9-ADF8-7E39660D82C6Q39981847-8A2560D2-1E1D-4C45-A1FC-A5321434F7D1
P2860
Identification by phage display and characterization of two neutralizing chimpanzee monoclonal antibodies to the hepatitis E virus capsid protein.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Identification by phage displa ...... atitis E virus capsid protein.
@ast
Identification by phage displa ...... atitis E virus capsid protein.
@en
type
label
Identification by phage displa ...... atitis E virus capsid protein.
@ast
Identification by phage displa ...... atitis E virus capsid protein.
@en
prefLabel
Identification by phage displa ...... atitis E virus capsid protein.
@ast
Identification by phage displa ...... atitis E virus capsid protein.
@en
P2093
P2860
P1433
P1476
Identification by phage displa ...... atitis E virus capsid protein.
@en
P2093
Emerson SU
Purcell RH
Schofield DJ
P2860
P304
P356
10.1128/JVI.74.12.5548-5555.2000
P577
2000-06-01T00:00:00Z